MarketCapTrends
KYNB
FibroGen, Inc. (KYNB)
NASDAQ · Healthcare

FibroGen, Inc. Cash on Hand 2013–2025

FibroGen, Inc. annual/quarterly cash on hand history from 2014 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.

  • FibroGen, Inc. cash on hand for the quarter ending December 31, 2025 were 47.9M, a 5.17% decrease year-over-year.
  • FibroGen, Inc. cash on hand for 2025 were 47.9M, a 5.17% decrease from 2024.
  • FibroGen, Inc. cash on hand for 2024 were 50.5M, a 38.10% decrease from 2023.
  • FibroGen, Inc. cash on hand for 2023 were 81.6M, a 47.62% decrease from 2022.
  • FibroGen, Inc. cash on hand for 2022 were 155.7M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
FibroGen, Inc. Annual Cash on Hand (Millions of US $)
2025$48
2024$50
2023$82
2022$156
2021$171
2020$678
2019$126
2018$89
2017$674
2016$174
2015$153
2014$165
FibroGen, Inc. Quarterly Cash on Hand (Millions of US $)
2025-12-31$48
2024-12-31$50
2023-12-31$82
2022-12-31$156
2021-12-31$171
2020-12-31$678
2019-12-31$126
2018-12-31$89
2017-12-31$674
2016-12-31$174
2015-12-31$153
2014-12-31$165

FibroGen, Inc. Cash on Hand — FAQ

FibroGen, Inc. (KYNB) cash on hand over the last 13 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see KYNB's cash on hand history?

The chart and table above show FibroGen, Inc.'s cash on hand by year and by quarter, including the growth rate.